West Pharmaceutical Services ( (WST) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
West Pharmaceutical Services’ stock movement was influenced by strong Q3 2025 results and a positive growth outlook, prompting several analysts to upgrade their price targets. Barclays, BofA, UBS, and Deutsche Bank all raised their targets, highlighting the company’s solid performance and promising future. However, Evercore ISI removed WST from its Tactical Outperform list, though it maintained an Outperform rating following the earnings report.
More about West Pharmaceutical Services
YTD Price Performance: -8.96%
Average Trading Volume: 651,876
Technical Sentiment Signal: Buy
Current Market Cap: $21.4B
For further insights into WST stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.